InvestorsHub Logo
Followers 4
Posts 1201
Boards Moderated 0
Alias Born 01/08/2018

Re: Cabocat post# 24734

Wednesday, 03/20/2019 2:47:18 PM

Wednesday, March 20, 2019 2:47:18 PM

Post# of 34698
I've never bothered worrying about the pharma side of the business - anything "pharma" to me translates to "a decade plus"... I bin it under "we'll get there when we'll get there," and never look at it again. If/When things [eventually] pop-up, I figure "Oh that's nice."

I'm genuinely hopeful that this is just a, "hey, just wanted everyone to know we're up to all this cool research; and it does not mean that's all we're up to," sort of update. (Read: That they're doing forward-looking research - to keep the pipeline full - does not mean someone hasn't already signed something with what's available today, to sell today.)

I also like the "nanotech" line, actually. Bunka himself has remarked in the past that it's (paraphrasing) "(1) interesting and quite viable, yet (2) possibly not all that healthy." Nanotech combined with Lexaria technology though may be/become the best of both worlds. If that happens, it'll probably blow everything nanotech that already exists right out of the water. (And hopefully be guarded by a patent that forces everyone to drop one and seek-out Lexaria for the other.)

Just some thoughts...

I'm (now very, apparently) long.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News